Issues Letter to Fellow Shareholders Regarding the Board’s Desperate and Self-Serving Attempt to Avoid Holding Browning…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
Ondo Finance Expands Focus to Asia Pacific, Making it Easier to Invest In US-Based Assets
HONG KONG–(BUSINESS WIRE)–Ondo Finance, a leading player in onchain finance, today announced its expansion into the…
Riley Keough Receives the IMDb STARmeter Award at the 2024 Sundance Film Festival
Riley Keough Receives the IMDb “Fan Favorite” STARmeter Award, as Determined by IMDbPro Data on the…
CMI ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Cummins Inc. (CMI)
RADNOR, Pa.–(BUSINESS WIRE)–#classaction–The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that…
MBLY CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Mobileye Global Inc. (MBLY)
RADNOR, Pa.–(BUSINESS WIRE)–#classaction–The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that…
Opdivo (nivolumab) Plus Yervoy (ipilimumab) Reduced the Risk of Disease Progression or Death by 79% Versus Chemotherapy in Patients with Microsatellite Instability-High or Mismatch Repair Deficient Metastatic Colorectal Cancer in CheckMate -8HW Trial
First presentation of data from the Phase 3 randomized trial shows statistically significant and clinically meaningful…
Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland
Dexcom’s first manufacturing facility in Europe will ensure the flow of products throughout EMEA New manufacturing…
Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries
Sensorion has received approval to initiate Phase 1/2 clinical trial of SENS-501 (OTOF-GT) in France as…
OSE Immunotherapeutics Highlights Clinical Portfolio Advancements and Provides 2024 Outlook
NANTES, France–(BUSINESS WIRE)–Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) updates on its clinical portfolio…
Lynk and Telikom Launch Initial Sat2Phone Service for Telikom Subscribers
FALLS CHURCH, Va.–(BUSINESS WIRE)–#Space—Lynk Global, Inc. (Lynk), the world’s leading satellite-direct-to-standard-phone (‘sat2phone’) telecoms provider, and Telikom…